Literature DB >> 29627146

Ebola virus vaccination and the longevity of total versus neutralising antibody response-is it enough?

Zachary A Bornholdt1, Steven B Bradfute2.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29627146     DOI: 10.1016/S1473-3099(18)30175-0

Source DB:  PubMed          Journal:  Lancet Infect Dis        ISSN: 1473-3099            Impact factor:   25.071


× No keyword cloud information.
  2 in total

1.  Reversion of Ebolavirus Disease from a Single Intramuscular Injection of a Pan-Ebolavirus Immunotherapeutic.

Authors:  Erin Kuang; Robert W Cross; Maria McCavitt-Malvido; Dafna M Abelson; Viktoriya Borisevich; Lauren Stuart; Krystle N Agans; Neil Mlakar; Arumugapradeep Marimuthu; Daniel J Deer; William S Shestowsky; Do Kim; Joan B Geisbert; Larry Zeitlin; Crystal L Moyer; Chad J Roy; Thomas W Geisbert; Zachary A Bornholdt
Journal:  Pathogens       Date:  2022-06-07

2.  Prominent Neutralizing Antibody Response Targeting the Ebolavirus Glycoprotein Subunit Interface Elicited by Immunization.

Authors:  Yimeng Wang; Katie A Howell; Jennifer Brannan; Krystle N Agans; Hannah L Turner; Ariel S Wirchnianski; Shweta Kailasan; Marnie Fusco; Andrey Galkin; Chi-I Chiang; Xuelian Zhao; Erica Ollmann Saphire; Kartik Chandran; Andrew B Ward; John M Dye; M Javad Aman; Thomas W Geisbert; Yuxing Li
Journal:  J Virol       Date:  2021-02-03       Impact factor: 6.549

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.